| Autor: |
Sakata, Ken‐ichiro, Yamazaki, Yutaka, Ohga, Noritaka, Sato, Jun, Asaka, Takuya, Yoshikawa, Kazuhito, Nakazawa, Seitaro, Sato, Chiharu, Nakamura, Yusuke, Kitagawa, Yoshimasa |
| Předmět: |
|
| Zdroj: |
Traditional & Kampo Medicine; Oct2016, Vol. 3 Issue 2, p120-122, 3p |
| Abstrakt: |
Aim At Hokkaido University Hospital, selective serotonin re-uptake inhibitors ( SSRI) or serotonin and norepinephrine re-uptake inhibitors ( SNRI) are the first-line medications for burning mouth syndrome ( BMS). Occasionally, when standard SSRI/ SNRI are deemed inappropriate because of certain side-effects, treatment incompatibility, age concerns, or doctor discretion, a kampo medicine called rikkosan can be used. The purpose of this study was to evaluate the effectiveness of rikkosan for BMS. Methods This retrospective study included 48 patients (four men, 44 women; mean age, 70 years) who were diagnosed with BMS in the present department between 2006 and 2014. Only patients who received rikkosan (7.5 g/day) for >4 weeks were included. Patients who were taking other medicines for BMS were excluded. Pain was assessed using a visual analog scale. Results Improvement was seen in 54% of patients (26/48). Conclusion Rikkosan is an effective alternative treatment for BMS. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
